Home   /   Taxonomy   /   Term

The Trendlines Group

Company in the news

Trendlines expects proceeds of $8 mil if sale of portfolio company is completed

Non-IFRS value of the portfolio at the end of June 2023 was US$152.8 million
Trendlines urges investors to focus on long-term growth, not lumpy earnings - THE EDGE SINGAPORE

Company in the news

Trendlines urges investors to focus on long-term growth, not lumpy earnings

The nature of Trendlines' business means lumpy earnings and revenue, but CEO Todd Dollinger is telling investors to look beyond.

SGX Research Series: 10 in 10

The Trendlines Group – from seed to market

"We believe that our company is undervalued by the market."
Phytolon closes $14.5 million in Series A Funding - THE EDGE SINGAPORE

Startups, Entrepreneurs, Digital economy

Phytolon closes US$14.5 million in Series A Funding

Phytolon, a portfolio company of The Trendlines Group, has secured $14.5 million in its latest Series A funding.
Trendlines to raise $20.27 million through proposed subscription of 168.9 mil new shares - THE EDGE SINGAPORE

Equity raising

Trendlines to raise $20.27 million through proposed subscription of 168.9 mil new shares

The new shares represent 21.35% of the existing share capital in the company and 17.59% of the enlarged share capital
Trendlines to divest stake in OrthoSpin for US$15.8 million - THE EDGE SINGAPORE

Innovation

Trendlines to divest stake in OrthoSpin for US$15.8 million

This investment will give Trendlines an internal rate of return of 165%.
The Trendlines Group will not be proceeding with its dual primary listing and securities offer on TASE - THE EDGE SINGAPORE

Company in the news

The Trendlines Group will not be proceeding with its dual primary listing and securities offer on TASE

The proposed listing on TASE was announced on April 5, after the company applied to the ISA to publish a prospectus on March 31.

M&A

Trendlines gets non-binding letter of intent for the acquisition of a portfolio company

Trendlines' minimum share of the sale proceeds is estimated at $19 mil.

Startups, Entrepreneurs, Digital economy

Trendlines Group sells portfolio company ApiFix to Nasdaq-listed OrthoPediatrics Corp

Trendlines has exited portfolio company ApiFix, which focuses on non-fusion treatment of idiopathic scoliosis, particularly among adolescents.

Company in the news

Iran-born investor Tchenguiz injects capital in Singapore-listed, Israel-based incubator Trendlines

SINGAPORE (Dec 13): While Israel-based The Trendlines Group sank into losses for 3QFY2019, its latest quarter, the company expects to be better positioned — with more resources, and time to grow the value of its portfolio of investments, following an in
×